How Stock Options and Warrants Will Hinder Marijuana Companies Over the Next 3 Years

I’ll be looking at two major considerations that long-term investors should note with marijuana companies such as Canopy Growth Corp. (TSX:WEED): stock options and warrants.

| More on:

The “green rush” bull market for cannabis and cannabis-related companies may only be getting started. Companies such as Canopy Growth Corp. (TSX:WEED), Aphria Inc. (TSX:APH), and Aurora Cannabis Inc. (TSXV:ACB) have seen valuations sky rocket over the past year; most marijuana companies have seen at least 200% growth over this rather short time.

The question is not whether the bull rush is over or getting started, but rather, what speed bumps or hiccups could these Canadian cannabis leaders encounter in the quarters and years ahead?

We have seen the impact the recent pesticides scandals affect Canopy (for product produced by Mettrum Ltd., a wholly owned subsidiary of Canopy) and Organigram Holdings Inc., another smaller Canadian cannabis producer; these scandals have slowed down the lightning-speed advances of these company’s stock prices for a short time.

I’ll be taking a look at another major consideration long-term investors should take note of: stock options and warrants.

Marijuana companies (and all companies in high-growth industries) generally have two major temptations early in their life cycle:

  1. They could raise money for working capital and capital expenditures through continuous rounds of equity financing at higher share prices.
  2. They could give management and employees share-purchase options or give investors stock warrants with equity issuances to bring the best talent on board for the team and ensure the maximum amount of capital is raised up front.

Speaking to the first point, studies have shown that companies tend to raise money when they perceive that the valuation the market has provided for their company exceeds their intrinsic value. Typically, when a secondary equity issuance is announced, the stock price drops due to the idea that the issuance itself signals to the market that the share price for the equity portion of the firm is overvalued.

Adding more shares to the existing pot dilutes the value of existing shares — another consideration which usually contributes to a decrease in the overall share price, at least for a time.

Irrespective of whether or not additional equity issuances dilute the existing pot of shares or signal to the market potential overvaluations, the share prices of these companies have continued to rise as the increases in the market capitalizations have outpaced any detracting factors.

Over time, should equity issuances continue at the current pace, the addition of new shares will begin to take its toll on earnings-per-share (EPS) metrics and other key metrics analysts use to value the equity portion of a more mature company, leading to potential share buybacks or dividend increases down the road (both of which are highly dependent on free cash flow generation and balance sheet health).

Speaking to the second point, the existence of large-scale employee stock options and talent-inducing incentives reek of similar tactics used in high-flying tech companies looking to attract talent from a relatively narrow base. I remain unconvinced that these incentives are necessary for management or employees, considering the nature of the business. Instead, I view these compensatory tools as “patronage” payments for early stage employees and as costly and unnecessary.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned.

More on Investing

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

think thought consider
Dividend Stocks

Down 10.88%: Is ATD Stock a Good Buy After Earnings?

Alimentation Couche-Tard (TSX:ATD) stock might not be the easy buy-case it once was. Here’s a look at what happened.

Read more »

money cash dividends
Dividend Stocks

TFSA Dividend Stocks: Earn $1,200/Year Tax-Free

Canadian stocks like Fortis are a must-have in your portfolio to earn tax-free yields for decades.

Read more »